Thursday, 29 August 2019
Wednesday, 28 August 2019
Investorideas.com - Apeks Supercritical Expands Global Headquarters with Opening of New Manufacturing Facility in Ohio
Investorideas.com - Apeks Supercritical Expands Global Headquarters with Opening of New Manufacturing Facility in Ohio
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $ISH.C) (CSE: $VAPN.C) (OTCQB: $DIGP) (CSE: $TER.C) (CSE: $OH.C)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE:
$ISH.C) (CSE: $VAPN.C) (OTCQB: $DIGP) (CSE: $TER.C) (CSE: $OH.C)
Delta, Kelowna, BC –August 28, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/08281ISH-VAPN-DIGP-TER-OH.asp
Today's podcast overview/transcript
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But
first, Scott McLeod, Gimaa (Chief) of the Nipissing First Nations, Ontario, commented on recent developments between the Ontario government and the Nipissing
First Nations. "Last week the Province of Ontario exercised authority
outside of its jurisdiction by issuing eight cannabis retail licenses to First
Nations communities. The Cannabis Act has downgraded the autonomy of First
Nations to maintain jurisdiction and create laws in our own territories by
forcing us to work with the Provinces instead of the Crown. First Nations must
have fair access to the economic potential to benefit our communities that the
lawful cannabis industry presents yet we are unnecessarily held back because an
error in the legislation is not being addressed because of an impending
election. Our communities cannot wait for the government to play politics with
our sovereignty or our potential to create jobs and economic opportunities for
our people. Our communities have been actively reaching out to Canadian
Government officials urging them to address this issue because we cannot afford
to wait and be left behind once again."
Inner Spirit
Holdings Ltd. (CSE:ISH), a Canadian company establishing a
national network of retail cannabis stores under its Spiritleaf brand, today announced it has filed its interim Financial
Statements and corresponding Management's Discussion and Analysis for the
quarter ended June 30, 2019. The filings are available for review on the
Company's SEDAR profile at
www.sedar.com as well as on the Company's website at
www.innerspiritholdings.com.
"The
lifting of the moratorium on cannabis retail store licences by Alberta Gaming,
Liquor and Cannabis (the "AGLC")
during the second quarter was precisely the springboard needed for Spiritleaf
to advance its business strategy. We also completed an over-subscribed $10
million financing in the quarter to help us further support the Spiritleaf
franchise network as well as open corporate-owned retail cannabis stores in
select locations. During the second quarter, we had six Spiritleaf cannabis
retail stores open, operating and generating financial results for the full
period. By the end of the third quarter, we're projecting our operations to
include up to 33 Spiritleaf retail cannabis stores, of which eight will be
corporate-owned outlets," said Darren Bondar, President and CEO of Inner
Spirit.
"We continue to implement our
business strategy by efficiently and effectively opening franchised and
corporate-owned Spiritleaf retail cannabis stores in key locations across the
country. We are operating in four provinces and growing our brand presence with
33 Spiritleaf stores projected to be fully operating by the end of the third
quarter and more than 40 by the end of this year. Our franchise model,
bolstered by selectively located corporate stores in jurisdictions where they
are permitted, is proving to be effective in helping us deliver top-quality
retail shopping experiences to more than 250,000 Spiritleaf customers to date.
We have strong support from our key strategic partners and shareholders –
Auxly, HEXO and Tilray – and we remain laser-focused on expanding our retail
network, enhancing our financial performance and creating value for
shareholders," said Bondar.
Vapen MJ (OTCQX:VAPNF) (CSE:
VAPN) a fully integrated agricultural
technology, services and property management company in the regulated cannabis
industry, announced that
it has been granted patent #10,231,948 for their metered dose inhaler from the
United States Patent and Trademark office.
This utility patent has simply one claim,
"an inhaler system consisting essentially of an actuator, a user
interchangeable canister assembly, purified cannabinoid from cannabis, isolated
terpene, ethanol, and a hydrofluorocarbon propellant. This patent is valid until 2038. Vapen MJ also has an unpublished patent
pending for additional claims on the inhaler system.
Vapen MJ is currently also doing white
label production of the CBD Inhaler and hopes to partner and/or license the
patent to a high-volume manufacturer that can reach more of the market with the
intrinsic benefits of the Inhaler delivery method.
The patent covers the Company's THC and
CBD inhaler device which uses a propellant to atomize the THC or CBD oil so it
can be deposited in the lungs, without heat. Vapen's inhalers offer a safe,
easy-to-use alternative to smoking, using edibles or other traditional methods
of consuming THC or CBD products. The Vapen inhaler administers a pressurized,
metered 10 milligram (mg) dose of pharmaceutical grade pure THC or CBD Isolate.
The result is a simple, convenient and accurate delivery system.
"We are very satisfied with the scope of
this patent covering the device, the delivered content, and the use of a
propellant, all key elements that enable this safe and convenient inhaler to
give customers simply the best way to get a precise and measured dose,"
commented Thai Nguyen, Founder and Chief Executive Officer of Vapen MJ Ventures.
"This broad utility patent brings tremendous value to our Company and our
brand, as well as new opportunities to drive sales, expand our market presence,
and increase shareholder value."
Digipath, Inc. (OTCQB:
DIGP), a leading independent testing
laboratory, data analytics and formulation firm focused on the developing
cannabis and hemp markets, announced that GroSciences, its wholly owned
subsidiary, has successfully completed beta-testing of its “Tru-Hemp ID” kit.
Tru-Hemp ID distinguishes hemp cultivars from drug-type I cannabis (which are
different genetic cultivars of cannabis) via a DNA test of the plant sample.
Under the 2018 Farm Bill that legalized
hemp cultivation, hemp is defined as having less than 0.3% delta-9-THC by dry
weight. As a result, compliance with the
2018 Farm Bill is usually determined by analyzing the THC content of a
particular plant sample. Tru-Hemp ID
offers a simpler method for determining the strain of a particular plant in the
form of a genetic test. A full analysis
of all data collected thus far using the Tru-Hemp ID kit that correlates the
genetic outcome of samples with their actual THC content will be forthcoming.
“Hemp farmers in North Carolina and
Vermont were very receptive to using the Tru-Hemp ID kit,” stated Cindy S.
Orser, PhD, Chief Science Officer, Digipath, Inc. “Farmers want to have the ability to
definitively verify what they are buying, particularly when purchasing hemp
seeds from other states or countries, or cannabis clones.”
Dr. Orser also spent time with the
Vermont Department of Agricultural staff, including the Vermont hemp program
director, Cary Giguere. Vermont, a
progressive cannabis state, already provides for the use of genetic testing to
discriminate hemp cultivars from drug-type I cannabis in lieu of a chemical
analysis of the mature flower for delta-9-THC content under the 2018 Farm Bill.
“It is rewarding to see our first genetic
product entering a successful beta test phase,” added Dr. Orser. “We are
enthusiastic about the market opportunity and the interest from hemp farmers
and hemp regulators.”
TerrAscend Corp. (CSE:
TER) (OTCQX:
TRSSF) the first and only cannabis company
with sales in Canada, the US and the EU,
today
announced the signing of definitive agreements for
a series of transactions to purchase ABI SF, LLC, which operates a Bay Area
cannabis cultivation facility and owns the State Flower brand. State Flower is
known for its ultra-premium cannabis flower and is currently sold through
dispensaries in California and Nevada, including The Apothecarium. TerrAscend
recently closed a series of transactions with The Apothecarium as noted in the
Company's press release of June 6, 2019. By agreeing to purchase State Flower
and bring aboard elite cultivation talent, TerrAscend will continue to provide
high quality product through its retail locations and will expand the State
Flower brand in multiple states.
TerrAscend has agreed to initially
acquire 49.9% of the equity of State Flower for total consideration of US$2.85M
from conversion of a previously issued convertible debenture and subject to
regulatory approvals.
TerrAscend has also extended a line of
credit of up to US$3.75M to State Flower for cultivation facility improvements
to expand production capacity. While
State Flower implements facility improvements, the parties will begin the
regulatory approval process for the full purchase of State Flower, under a
Securities Purchase Agreement.
TerrAscend also has future rights to use the State Flower brand pursuant
to a license agreement.
TerrAscend has agreed to purchase the
remaining 50.1% equity of State Flower for total consideration based on future
revenue over a predetermined twelve-month period. The transaction is subject to regulatory
approvals by various local and state authorities, as well as certain customary
closing conditions. Several of the
owners of The Apothecarium and their related entities have an ownership
interest in State Flower.
"We're excited to add the
prestigious State Flower brand to our portfolio," said Matthew Johnson, President
of TerrAscend Corp., and TerrAscend USA, Inc. "Daniel Wacks and Jeremy
Cohen are skilled cannabis cultivators with years of experience operating in a
highly regulated market and we are thrilled to work with them to expand the
State Flower facilities and brand presence. "
"Through our work with The
Apothecarium and TerrAscend, it's clear that we've found a great strategic and
cultural fit," said Daniel Wacks, President of State Flower. "We're
proud of the brand we've built and excited to have found a partner who
recognizes the quality of our team. We look forward to working together to
build best-in-class cultivation capabilities in all jurisdictions where
TerrAscend operates, to expand the State Flower brand presence, and become part
of an inspirational team that's making major progress towards becoming one of
the top companies in the sector."
CannaRoyalty
Corp. d/b/a Origin House (CSE:
OH) (OTCQX:
ORHOF),
a North American cannabis products and brands company today
announced its financial results for the three and
six-month periods ended June 30, 2019. All figures are reported in Canadian
dollars ($), unless otherwise indicated. Origin House's financial statements
are prepared in accordance with International Financial Reporting Standards.
For a more comprehensive overview of the
Corporate and Financial highlights presented in this press release, please
refer to Origin House's Management Discussion and Analysis of the Financial
Condition and Results of Operations for the three and six months ended June 30,
2019, and the Company's Condensed Interim Consolidated Financial Statements for
the three and six months ended June 30, 2019, which will be filed on SEDAR by
August 29, 2019.
Marc Lustig, Chairman and CEO of Origin
House commented, "I am very proud of the entire Origin House team for
generating another quarter of record revenue growth, leveraging the California
brand support and distribution platform we built over the past several years,
to deliver results for shareholders. It speaks to the strength and maturity of
our organization that we were able to increase our share of shelf in California
while preparing to integrate with Cresco Labs. To that end, in this quarter, we
successfully executed on the sale of Alternative Medical Enterprises LLC generating
a 156% return on investment, our distribution division Continuum entered into a
distribution agreement with Cresco and began distributing Cresco branded
products across California, and we have made substantial progress on
post-closing groundwork."
Mr. Lustig continued, "In
California, we have built a foundation that is capable of supporting a much
larger business and expect to begin to drive significant operating leverage as
we continue to grow revenue. With additional regulatory pressure on the illegal
market in California, we expect 2020 to be a big year in the state. I am as
confident as ever that the combination of Cresco Labs' scale, expertise and
brand portfolio with Origin House's proven track record of leveraging our
California-wide distribution footprint, is the best way for shareholders to
participate in this growth. Together, we will be well-positioned to build a
national, and one day, global house of brands."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure is posted for each compensated news release,
content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Sector Snapshot - The Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA) (OTC: $EDXC)
Sector Snapshot - The Lucrative #CBD #Pet Products Market (OTC: $HIPH) (OTC: $LRSV) (OTC: $MJNA) (OTC: $EDXC)
Point Roberts WA, Delta BC – August 28, 2019 - Investorideas.com, a leading investor news resource covering cannabis and pet stocks releases a snapshot reporting on the continued growth in both product development and availability in the CBD pet product market as more companies enter the space and consumer awareness and demand increase.
In a recent news article, “In the U.S., sales of CBD products for all species are approaching US$500 million, reported David Lummis, lead pet market analyst for Packaged Facts, in a column in Pet Product News. Citing data reported by the Washington Post, he said those sales are projected to soar to as much as US$22 billion by 2024.”
The article continued, “Packaged Facts’ own data shows that sales of CBD products for pets specifically are only a fraction of the total, about U.S.$25 million, but growing quickly. Among U.S. pet owners surveyed by Packaged Facts, 39% of dog owners and 34% of cat owners agree they like the idea of CBD supplements for their pets. Additionally, 29% of dog and cat owners agree they would be interested in purchasing CBD supplements for their pets if they were legal.”
“Through the years, the pet supplements market has benefited from the popularization and cross-over of various ingredients from the human side, such as glucosamine and omega fatty acids,” says David Sprinkle, research director for Packaged Facts. “Looking back, however, it’s hard to recall anything making more of a splash in both human and pet supplements than CBD.”
American Premium Water Corporation (OTC: HIPH) recently announced that its Lynks CBD Pet Water, a joint venture with Link Reservations Inc. (OTC: LRSV) is now available for sale on SingleSeed.com. The Company is launching Lynks CBD a day earlier than the previously announced date of August 29th. The CBD used in this product is hemp-derived.
Read this in full at https://www.investorideas.com/news/2019/cannabis/08281OTCHIPH-CBD-PetProduct.asp
American Premium Water Corporation CEO, Ryan Fishoff stated “I’m happy to announce that Lynks CBD Pet Water is now available for sale on SingleSeed.com! This product was fast tracked for development in the spring, and we were able to deliver it early! Beverages designed for pets has been an overlooked category in the pet space. There are very few pre-packaged waters designed for pets available in the marketplace, and certainly none that are infused with our proprietary Hydro Nano CBD technology. I am confident that Lynks CBD will quickly establish itself as the market leader in the pet sector. We’re really excited that the Company now has a product to enter the pet market, one of the largest consumer markets in the world.”
Rene Lauritsen, CEO of LinkRes Pets commented, “Today is a great day for our Company. We are excited to expand our offerings for pets and enter the pet beverage market. This product is quite revolutionary; there aren’t many pet beverages on the market, and we are quite confident we will be able to grab significant market share with this product. We have received a number of inquiries from retailers looking to carry this product; I look forward to working with Ryan and his team on fully developing the distribution strategy for Lynks CBD Pet Water.”
The American Pet Products Association estimates that the US pet product industry will be worth over $75 billion in 2019. The Brightfield Group projects that the CBD Pet Product Market will represent over $1.5 billion in sales, of an estimated $23 billion CBD market by 2023. Pet owners are typically more affluent, as a research report by Research and Marketing estimates that over 55% of US households own a pet, and of that group, they are more likely to be in a higher income household than non-pet owners.
CBD Unlimited, Inc., formerly known as Endexx Corporation (OTC: EDXC), a provider of innovative phytonutrient-based food and nutritional products, recently exhibited at SuperZoo.
At SuperZoo, the Company exhibited its veterinarian-approved Phyto-Bites and Soft Chew CBD pet products which are THC-free, neither heated nor baked, and involve a dual-delivery method to provide effective and safe absorption. CBD Unlimited looks forward to continuing to promote this unique product line and highlighting the benefits that cats and dogs can receive from CBD.
CBD Unlimited's Chief Medical Officer, Dr. Daniel Kiddy, has assisted the Company with its analysis of cannabinoids and its effects on each delivery system. From years of continuous research, CBD Unlimited prides itself on formulating properly dosed products ranging across several pet sizes including cats, dogs and horses. The Company’s one-of-a-kind technology delivers CBD to both CB1 and CB2 receptors in the Endocannabinoid System.
“CBD Unlimited is passionate about formulating the best products for our four-legged friends that provide optimal results,” CEO & Chairman Todd Davis stated. “Our CBD-infused Soft Chews are proven to have one of the most expeditious and effective delivery systems. We are excited about this opportunity to demonstrate the positive effects of CBD for families’ loved ones.”
Medical Marijuana, Inc. (OTC: MJNA), recently announced that its subsidiary HempMeds® has released its Hemp for Pets pet cannabidiol (CBD) product line in celebration of National Dog Day.
Hemp for Pets by HempMeds® was created to help improve the lives of all pets, from nose to tail. The Company, a proud member of the National Pet Supplement Council (NPSC), aims to improve the lives of pets and people naturally with a commitment to ethically-sourced hemp CBD extract and natural ingredients, dedicated scientific expertise and innovation backed by the strictest efficacy testing.
"We don't just want to create great products, we want to do great work. National Dog Day isn't just a great opportunity to celebrate the dogs who have become a part of our family, but also recognize the many dogs who are currently in need of homes or care. There are so many pet parents, rescues and shelters that HempMeds® can now aid by providing them with the CBD products they need to help improve the wellness of their pets," said HempMeds® President, Todd Morrow. "This is very near to my heart and I am looking forward to spearheading this initiative through our Animals in Need Program."
According to Nielsen analysts, the US pet food and treats market in 2018 reached nearly $33 billion across various retail channels, including local pet stores, vet clinics, e-commerce sites and more. Compared to 2017 sales, this represents a five percent, or $1.5 billion, increase. The Brightfield Group recently reported that the US CBD pet product market was worth $32 million in 2018 and is estimated to grow to at least $1.16 billion by 2022.
"There are many studies providing evidence that CBD has a variety of wellness benefits for pets including improved cardiovascular function, neurological health and behavior, healthy joints and hips, and healthy skin and coats," said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. "Our pet-focused products are made with the Company's Triple Lab Tested™ full-spectrum hemp oil and THC-free isolate to offer pets the same high quality that we've been providing to humans for many years."
The company also recently attended SuperZoo, the most-attended pet industry show in North America, in Las Vegas, August 20-22.
This rise in demand is bringing everyone to the market including GCH, Inc., the development company co-founded by Willie Nelson and his wife, Annie Nelson, which is adding another brand to its portfolio of popular cannabis and hemp product lines, Willie’s Rescue, an array of hemp products for internal and external use in dogs, cats and horses.
“Our mission is to utilize the benefits of the hemp plant to positively impact the lives of companion animals,” said Elizabeth Hogan, Vice President of Brands for GCH, Inc.
“As longtime animal advocates and pet owners, our family believes that the hemp plant has benefited our own animals,” the Nelsons said in a statement. “We want you and your best friends to experience the potential benefits of hemp. That’s why we created Willie’s Rescue and are donating a portion of each sale to help find loving homes for animals in need.”
While CBD products may remain in somewhat of a grey area legally, consumer demand is driving this industry forward with the pet segment taking up a larger and larger segment. People love their pets and it seems most pet owners want the option of quality CBD pet products, and through some companies recent developments, they’re now having more and more options to choose from.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
Follow us on Cannabis Social Media
Disclaimer/Disclosure Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com – third party . Learn more about costs and our services https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories
Tuesday, 27 August 2019
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Interview with Matt Markiewicz, The Cannabis ETF (NYSE: $THCX)
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Interview
with Matt Markiewicz, The Cannabis ETF (NYSE: $THCX)
Delta, Kelowna, BC –August 27, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/08271NYSETHCX-MattMarkiewicz.asp
Today's podcast overview/transcript
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast I interviewed Matt Markiewicz, the Managing Director of Innovation Shares which also manages The Cannabis ETF (NYSE: THCX), regarding the recent news surrounding
THCX as well as the cannabis industry in general.
The
Cannabis ETF (THCX) is an ETF that provides investors with a liquid and
diversified vehicle to gain access to the explosive growth of the legal
cannabis market.
There are a lot of ETF firms out there
and over 2k ETFs in the United States. What makes Innovation Shares different?
“The unique thing about Innovation shares
is how we build the index that the fund attracts. Part of our methodology is
using a patent pending process that applies a natural language processing
algorithm, that’s rooted in artificial intelligence, that looks at media
sentiment for stocks related to a particular theme. We are trying to only
include stocks with positive sentiment. Investor sentiment/behaviour is often
influenced by what the media says about the stocks. We apply this process,
what’s called a sentiment overlay, into the construction of our portfolios.
That’s what really differentiates us.”
What are some of the other factors that
influence their decisions to add or remove certain companies from the ETF?
“A stock must a have a minimum 100
million dollar market cap U.S. in order to even be considered in the portfolio.
It also has to trade on one of 5 exchanges in the world, which are the ASX,
TSX, TSX-V, NYSE or NASDAQ. We also have liquidity requirements as well and we
rebound this portfolio monthly and we apply a modified market cap approach.”
Your ETF has had a fair amount of
movement in the last few months, could you discuss some of that in detail?
“We did have a fairly active reshuffling
of the portfolio this past rebalance. We added Valens, CBDMD, Fire and Flower as well as a company
called Enwave who has a proprietary
drying technology used in food which is now being applied to cannabis, which is
quite an interesting story. We also removed Innovative Industrial Properties
and Canntrust. It was a very active rebalance period for us. That’s not always
going to be the case but there were a lot of big news items, some bad some good
for the cannabis industry over this summer, so that’s why you’re seeing a lot
of activity.”
When looking at the proposed Safe
|banking Act, how much do you see this impacting the U.S. cannabis industry as
well as your ETF?
“The question for us is will the
potential passage of the safe banking act allow companies easier access to
capital markets, or in other word list on the NYSE or NASDAQ. As I mentioned we
have a requirement that stocks have to trade on one of those exchanges. From a
funds specific standpoint I think it would be massive. From a broader
perspective, it would open up the market to the larger equity space.Right now
you’re still not seeing many of the largest fund managers in the world getting
involved with cannabis. If the safe banking act will allow those institutions
to become more comfortable with owning the stock of these public companies,
then this could be a watershed moment for the industry.”
The U.S. and Canada get a large spotlight
in the Cannabis industry, how much attention are you paying to the
international scope of the industry?
“I think the growth of the global
cannabis story is quite interesting. There are companies that are trading now
or will be trading soon that will have access to these global markets. As
regulatory changes occur in markets around the world, they definitely bare
watching. It's going to be an opportunity for revenue expansions, or multiple
expansions for the companies entrenching themselves in these markets.” When
asked which companies are included in the ETF on an international level Matt
included, Khiron Life Sciences and Pharmacielo.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...